-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Poor Treatment Outcomes of Young (<60 Years) African American Patients Diagnosed with Acute Myeloid Leukemia

Program: Scientific Workshops @ ASH
Session: Hematologic Malignancies
Wednesday, December 2, 2020, 7:45 AM-8:25 AM

Ann-Kathrin Eisfeld, MD

Division of Hematology, The Ohio State University, Columbus, OH

Disclosures: Eisfeld: Vigeo Therapeutics: Consultancy, Other: husband consultancy (not own); Karyopharm: Current Employment, Current equity holder in publicly-traded company, Other: husband employment (not own employment).

Previous Presentation | Next Presentation >>